Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy

Rezum therapy is in emerging minimally invasive treatment for BPH. Complications of Rezum are underreported in the literature. We report a case of a 61-year-old male patient who presented to ED two months after Rezum with hematuria and clot retention. US showed prostate size of 315 g with cystic cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkeraithe, Fawaz, Bin Hamri, Saeed, Alsaleh, Faisal, Alasmari, Faisal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Endourology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188957/
https://www.ncbi.nlm.nih.gov/pubmed/35707222
http://dx.doi.org/10.1016/j.eucr.2022.102125
_version_ 1784725488341614592
author Alkeraithe, Fawaz
Bin Hamri, Saeed
Alsaleh, Faisal
Alasmari, Faisal
author_facet Alkeraithe, Fawaz
Bin Hamri, Saeed
Alsaleh, Faisal
Alasmari, Faisal
author_sort Alkeraithe, Fawaz
collection PubMed
description Rezum therapy is in emerging minimally invasive treatment for BPH. Complications of Rezum are underreported in the literature. We report a case of a 61-year-old male patient who presented to ED two months after Rezum with hematuria and clot retention. US showed prostate size of 315 g with cystic changes. The patient was managed with TURP and unexpectedly showed big contained hematoma below the bladder neck which was evacuated with adequate hemostasis.
format Online
Article
Text
id pubmed-9188957
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91889572022-06-14 Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy Alkeraithe, Fawaz Bin Hamri, Saeed Alsaleh, Faisal Alasmari, Faisal Urol Case Rep Endourology Rezum therapy is in emerging minimally invasive treatment for BPH. Complications of Rezum are underreported in the literature. We report a case of a 61-year-old male patient who presented to ED two months after Rezum with hematuria and clot retention. US showed prostate size of 315 g with cystic changes. The patient was managed with TURP and unexpectedly showed big contained hematoma below the bladder neck which was evacuated with adequate hemostasis. Elsevier 2022-06-04 /pmc/articles/PMC9188957/ /pubmed/35707222 http://dx.doi.org/10.1016/j.eucr.2022.102125 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Endourology
Alkeraithe, Fawaz
Bin Hamri, Saeed
Alsaleh, Faisal
Alasmari, Faisal
Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy
title Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy
title_full Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy
title_fullStr Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy
title_full_unstemmed Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy
title_short Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy
title_sort unexpected encapsulated hematoma after rezum therapy: first outcome of an emerging therapy
topic Endourology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188957/
https://www.ncbi.nlm.nih.gov/pubmed/35707222
http://dx.doi.org/10.1016/j.eucr.2022.102125
work_keys_str_mv AT alkeraithefawaz unexpectedencapsulatedhematomaafterrezumtherapyfirstoutcomeofanemergingtherapy
AT binhamrisaeed unexpectedencapsulatedhematomaafterrezumtherapyfirstoutcomeofanemergingtherapy
AT alsalehfaisal unexpectedencapsulatedhematomaafterrezumtherapyfirstoutcomeofanemergingtherapy
AT alasmarifaisal unexpectedencapsulatedhematomaafterrezumtherapyfirstoutcomeofanemergingtherapy

Ejemplares similares